3-43032303-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001129908.3(GASK1A):c.40C>T(p.Arg14Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000462 in 1,537,304 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001129908.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GASK1A | NM_001129908.3 | c.40C>T | p.Arg14Trp | missense_variant | 2/5 | ENST00000430121.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GASK1A | ENST00000430121.3 | c.40C>T | p.Arg14Trp | missense_variant | 2/5 | 5 | NM_001129908.3 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.0000460 AC: 7AN: 152174Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000137 AC: 21AN: 153226Hom.: 0 AF XY: 0.000160 AC XY: 13AN XY: 81092
GnomAD4 exome AF: 0.0000462 AC: 64AN: 1385130Hom.: 0 Cov.: 38 AF XY: 0.0000544 AC XY: 37AN XY: 680182
GnomAD4 genome ? AF: 0.0000460 AC: 7AN: 152174Hom.: 0 Cov.: 33 AF XY: 0.0000673 AC XY: 5AN XY: 74324
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 14, 2023 | The c.40C>T (p.R14W) alteration is located in exon 2 (coding exon 2) of the FAM198A gene. This alteration results from a C to T substitution at nucleotide position 40, causing the arginine (R) at amino acid position 14 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at